These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10597754)

  • 1. Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.
    Meek PD; Davis SN; Collins DM; Gidal BE; Rutecki PA; Burstein AH; Fischer JH; Leppik IE; Ramsay RE
    Arch Intern Med; 1999 Dec 13-27; 159(22):2639-44. PubMed ID: 10597754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
    Popławska M; Borowicz KK; Czuczwar SJ
    Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.
    DeToledo JC; Ramsay RE
    Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of fosphenytoin: options for the management of seizures.
    Ramsay RE; DeToledo J
    Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department.
    Rudis MI; Touchette DR; Swadron SP; Chiu AP; Orlinsky M
    Ann Emerg Med; 2004 Mar; 43(3):386-97. PubMed ID: 14985668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular use of fosphenytoin: an overview.
    Uthman BM; Wilder BJ; Ramsay RE
    Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric use of intravenous and intramuscular phenytoin: lessons learned.
    Wheless JW
    J Child Neurol; 1998 Oct; 13 Suppl 1():S11-4; discussion S30-2. PubMed ID: 9796746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fosphenytoin and status epilepticus.
    Brown J
    Hosp Med; 1999 Jan; 60(1):70-1. PubMed ID: 10197108
    [No Abstract]   [Full Text] [Related]  

  • 12. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data vs opinion, phenytoin vs fosphenytoin: the saga continues.
    Labiner DM
    Arch Intern Med; 1999 Dec 13-27; 159(22):2631-2. PubMed ID: 10597752
    [No Abstract]   [Full Text] [Related]  

  • 14. Fosphenytoin injection introduced as replacement for Dilantin injection.
    Am J Health Syst Pharm; 1996 Oct; 53(19):2249. PubMed ID: 8893059
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus.
    Srivastava K; Bhartiya S; Gavli V; Patil R; Rajadhyaksha S
    Indian Pediatr; 2020 Mar; 57(3):218-221. PubMed ID: 32198860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with fosphenytoin in children.
    Morton LD
    J Child Neurol; 1998 Oct; 13 Suppl 1():S19-22; discussion S30-2. PubMed ID: 9796748
    [No Abstract]   [Full Text] [Related]  

  • 17. Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital.
    Tiamkao S; Chitravas N; Jitpimolmard S; Sawanyawisuth K
    J Med Assoc Thai; 2005 Nov; 88(11):1638-41. PubMed ID: 16471113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin.
    DeToledo JC; Lowe MR; Rabinstein A; Villaviza N
    Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605
    [No Abstract]   [Full Text] [Related]  

  • 20. Fosphenytoin in infants of extremely low birth weight.
    Kriel RL; Cifuentes RF
    Pediatr Neurol; 2001 Mar; 24(3):219-21. PubMed ID: 11301224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.